155 related articles for article (PubMed ID: 22983667)
1. Establishment and characterization of xenograft models of human neuroblastoma bone metastasis.
Zhao H; Cai W; Li S; Da Z; Sun H; Ma L; Lin Y; Zhi D
Childs Nerv Syst; 2012 Dec; 28(12):2047-54. PubMed ID: 22983667
[TBL] [Abstract][Full Text] [Related]
2. Characterization of neuroblastoma bone invasion/metastasis in established bone metastatic model of SY5Y and KCNR cell lines.
Zhao H; Cai W; Li S; Da Z; Sun H; Ma L; Lin Y; Zhi D
Childs Nerv Syst; 2013 Jul; 29(7):1097-105. PubMed ID: 23559392
[TBL] [Abstract][Full Text] [Related]
3. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells.
Corey E; Quinn JE; Bladou F; Brown LG; Roudier MP; Brown JM; Buhler KR; Vessella RL
Prostate; 2002 Jun; 52(1):20-33. PubMed ID: 11992617
[TBL] [Abstract][Full Text] [Related]
5. The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.
Meier R; Mühlethaler-Mottet A; Flahaut M; Coulon A; Fusco C; Louache F; Auderset K; Bourloud KB; Daudigeos E; Ruegg C; Vassal G; Gross N; Joseph JM
PLoS One; 2007 Oct; 2(10):e1016. PubMed ID: 17925864
[TBL] [Abstract][Full Text] [Related]
6. Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis.
Khanna C; Jaboin JJ; Drakos E; Tsokos M; Thiele CJ
In Vivo; 2002; 16(2):77-85. PubMed ID: 12073775
[TBL] [Abstract][Full Text] [Related]
7. In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts.
Joseph JM; Gross N; Lassau N; Rouffiac V; Opolon P; Laudani L; Auderset K; Geay JF; Mühlethaler-Mottet A; Vassal G
Int J Cancer; 2005 Mar; 113(6):881-90. PubMed ID: 15514941
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of novel local and metastatic human neuroblastoma variants.
Nevo I; Sagi-Assif O; Edry Botzer L; Amar D; Maman S; Kariv N; Leider-Trejo LE; Savelyeva L; Schwab M; Yron I; Witz IP
Neoplasia; 2008 Aug; 10(8):816-27. PubMed ID: 18683320
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
[TBL] [Abstract][Full Text] [Related]
10. Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate.
Sohara Y; Shimada H; Scadeng M; Pollack H; Yamada S; Ye W; Reynolds CP; DeClerck YA
Cancer Res; 2003 Jun; 63(12):3026-31. PubMed ID: 12810621
[TBL] [Abstract][Full Text] [Related]
11. Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma.
Zhang L; Yeger H; Das B; Irwin MS; Baruchel S
Neoplasia; 2007 Jan; 9(1):36-46. PubMed ID: 17325742
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
[TBL] [Abstract][Full Text] [Related]
13. Human neuroblastoma serially transplanted in nude mice and metastases.
Hata JI; Ueyama Y; Tamaoki N; Furukawa T; Morita K
Cancer; 1978 Aug; 42(2):468-73. PubMed ID: 679149
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
15. Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice.
Sartelet H; Durrieu L; Fontaine F; Nyalendo C; Haddad E
In Vivo; 2012; 26(1):19-29. PubMed ID: 22210712
[TBL] [Abstract][Full Text] [Related]
16. The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer.
Wang N; Reeves KJ; Brown HK; Fowles AC; Docherty FE; Ottewell PD; Croucher PI; Holen I; Eaton CL
J Exp Clin Cancer Res; 2015 Oct; 34():124. PubMed ID: 26480944
[TBL] [Abstract][Full Text] [Related]
17. Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model.
Fritz V; Louis-Plence P; Apparailly F; Noël D; Voide R; Pillon A; Nicolas JC; Müller R; Jorgensen C
Bone; 2007 Apr; 40(4):1032-40. PubMed ID: 17251073
[TBL] [Abstract][Full Text] [Related]
18. The effect of Neovastat (AE-941) on an experimental metastatic bone tumor model.
Weber MH; Lee J; Orr FW
Int J Oncol; 2002 Feb; 20(2):299-303. PubMed ID: 11788892
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
Fisher JL; Thomas-Mudge RJ; Elliott J; Hards DK; Sims NA; Slavin J; Martin TJ; Gillespie MT
Cancer Res; 2006 Apr; 66(7):3620-8. PubMed ID: 16585187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
